Clinical Trial Update: Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for Oxaliplatin [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating atezolizumab for MSI-H/MMR-D stage II high-risk and stage III colorectal cancer patients ineligible for oxaliplatin; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING